CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 263 filers reported holding CONMED CORP in Q4 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403 | -25.9% | 4 | 0.0% | 0.00% | – |
| Q2 2023 | $544 | +31.1% | 4 | 0.0% | 0.00% | – |
| Q1 2023 | $415 | +16.9% | 4 | 0.0% | 0.00% | – |
| Q4 2022 | $355 | – | 4 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 4 | -55.6% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 9 | -10.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 10 | +150.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 4 | -50.0% | 0.00% | – |
| Q4 2020 | $0 | – | 8 | +100.0% | 0.00% | – |
| Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 4 | -33.3% | 0.00% | – |
| Q4 2019 | $1,000 | – | 6 | +100.0% | 0.00% | – |
| Q3 2019 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |